Search
for
Sort by
Research 61–90 of 1000+
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Therapies and nanotherapies for cervical cancer (Review)
- Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
- Applications of Antioxidant Nanoparticles in Immune-Mediated Inflammatory Diseases
- Alopecia Areata Associated with Dupilumab: National Database Study
- Mechanisms of Impaired Skeletal Muscle Regeneration and Therapeutic Approaches in Aging and Chronic Disease
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
- Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments
- Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars
- Perifollicular Inflammation and Fibrosis in Androgenetic Alopecia: Implications for Diagnosis and Treatment - A Comparative Histopathologic and Clinical Study with Normal-Appearing Scalp
- Pathophysiological mechanisms of hair follicle regeneration and potential therapeutic strategies
- Proceedings of the Ninth World Congress for Hair Research (2015)
- Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- Extracellular vesicles in age-related diseases: disease pathogenesis, intervention, and biomarker
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- The Involvement of RIPK1 in Alopecia Areata
- BH09 Patient experience of off-label Janus kinase inhibitor use for alopecia areata in a cohort of 34 patients from a single UK practitioner: exploring changing trends in healthcare provision and access to drug treatments
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Molecular Mechanisms and Targeted Therapeutics in Androgenetic Alopecia: From Signaling Pathways to Regenerative Approaches
- 397 Predictive modeling of drug response and mechanism of action in alopecia areata clinical trials
- Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Recent Advances in Drug Development for Hair Loss
- Editorial: Targeted immunological therapies in dermatology
- Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation